News list for "artelo"

Solana treasury company Artelo Biosciences completes $3 million rights issue

Nasdaq-listed Solana treasury company Artelo Biosciences announced the issuance of 640,924 common shares to the public at a price of $4.40 per share, raising a total of approximately $3 million. Artelo Biosciences is a clinical pharmaceutical company that has previously announced the official launch of a Solana-based digital asset treasury strategy and will invest part of its capital in the purchase of SOL tokens. As of now, it holds 45,883 SOL.

clock
2025-09-09 08:24:27
Solana财库公司Artelo Biosciences完成300万美元配股募资

纳斯达克上市的Solana财库公司Artelo Biosciences宣布以每股4.40美元的价格向公众发行640,924股普通股,募集总计约300万美元资金,Artelo Biosciences是一家临床制药公司,此前已宣布正式启动基于Solana的数字资产财库战略并将部分资本投入购买SOL代币,截至目前持有45883枚SOL。

clock
2025-09-09 08:24:27
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.